Global blood culture tests market will reach $9,621.7 million by 2031, growing by 8.2% annually over 2021-2031, driven by the rising prevalence of bloodstream infections, increasing number of sepsis cases and high cost of treatment, rising geriatric population, and the rising demand for rapid diagnostic techniques amid the COVID-19 pandemic.
Highlighted with 84 tables and 87 figures, this 165-page report “Global Blood Culture Tests Market 2021-2031 by Product (Consumables, Instruments, Software and Services), Method (Conventional, Automated), Technology (Culture-Based, Molecular, Proteomics, Others), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global blood culture tests market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global blood culture tests market in every aspect of the classification from perspectives of Product, Method, Technology, Application, End User, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Consumables
o Blood Culture Media
o Assay Kits & Reagents
o Blood Culture Accessories
• Instruments
o Automated Blood Culture Systems
o Supporting Laboratory Equipment
• Software and Services
Based on Method, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Conventional/Manual Methods
• Automated Methods
Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Culture-Based Technologies
• Molecular Technologies
o Microarrays
o Polymerase Chain Reaction (PCR)
o PNA-FISH
• Proteomics Technology
• Other Technologies
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Bacteremia
• Fungemia
• Mycobacterial Detection
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospital Laboratories
• Reference Laboratories
• Academic Research Laboratories
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company (BD)
Binder Gmbh
Biobase Biotech (Jinan) Co., Ltd.
BioMĂ©rieux SA
Bruker Corporation
Carl Zeiss Ag
Cepheid Inc. (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Luminex Corporation
Neogen Corporation (Abtek Biologicals)
OpGen Inc.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter’s Fiver Forces Analysis 38
3 Segmentation of Global Market by Product 42
3.1 Market Overview by Product 42
3.2 Consumables 44
3.2.1 Blood Culture Media 45
3.2.2 Assay Kits & Reagents 46
3.2.3 Blood Culture Accessories 47
3.3 Instruments 48
3.3.1 Automated Blood Culture Systems 49
3.3.2 Supporting Laboratory Equipment 50
3.4 Software and Services 51
4 Segmentation of Global Market by Method 52
4.1 Market Overview by Method 52
4.2 Conventional/Manual Methods 54
4.3 Automated Methods 55
5 Segmentation of Global Market by Technology 56
5.1 Market Overview by Technology 56
5.2 Culture-Based Technologies 58
5.3 Molecular Technologies 59
5.3.1 Microarrays 60
5.3.2 Polymerase Chain Reaction (PCR) 61
5.3.3 PNA-FISH 62
5.4 Proteomics Technology 63
5.5 Other Technologies 64
6 Segmentation of Global Market by Application 65
6.1 Market Overview by Application 65
6.2 Bacteremia 67
6.3 Fungemia 68
6.4 Mycobacterial Detection 69
7 Segmentation of Global Market by End User 70
7.1 Market Overview by End User 70
7.2 Hospital Laboratories 72
7.3 Reference Laboratories 73
7.4 Academic Research Laboratories 74
7.5 Other End Users 75
8 Segmentation of Global Market by Region 76
8.1 Geographic Market Overview 2021-2031 76
8.2 North America Market 2021-2031 by Country 80
8.2.1 Overview of North America Market 80
8.2.2 U.S. 84
8.2.3 Canada 87
8.2.4 Mexico 89
8.3 European Market 2021-2031 by Country 91
8.3.1 Overview of European Market 91
8.3.2 Germany 95
8.3.3 U.K. 97
8.3.4 France 99
8.3.5 Spain 101
8.3.6 Italy 103
8.3.7 Russia 105
8.3.8 Rest of European Market 107
8.4 Asia-Pacific Market 2021-2031 by Country 109
8.4.1 Overview of Asia-Pacific Market 109
8.4.2 Japan 113
8.4.3 China 116
8.4.4 Australia 118
8.4.5 India 120
8.4.6 South Korea 122
8.4.7 Rest of APAC Region 124
8.5 South America Market 2021-2031 by Country 126
8.5.1 Argentina 129
8.5.2 Brazil 131
8.5.3 Chile 133
8.5.4 Rest of South America Market 135
8.6 MEA Market 2021-2031 by Country 136
8.6.1 UAE 139
8.6.2 Saudi Arabia 141
8.6.3 South Africa 143
8.6.4 Other National Markets 145
9 Competitive Landscape 146
9.1 Overview of Key Vendors 146
9.2 New Product Launch, Partnership, Investment, and M&A 149
9.3 Company Profiles 150
Autobio Diagnostics Co., Ltd. 150
Becton, Dickinson and Company (BD) 152
Binder Gmbh 153
Biobase Biotech (Jinan) Co., Ltd. 154
BioMĂ©rieux SA 155
Bruker Corporation 156
Carl Zeiss Ag 157
Cepheid Inc. (Danaher Corporation) 158
F. Hoffmann-La Roche Ltd. 159
Luminex Corporation 160
Neogen Corporation (Abtek Biologicals) 161
OpGen Inc. 162
T2 Biosystems, Inc. 163
Thermo Fisher Scientific Inc. 164
RELATED REPORTS 165
Selected Key Players:
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company (BD)
Binder Gmbh
Biobase Biotech (Jinan) Co., Ltd.
BioMĂ©rieux SA
Bruker Corporation
Carl Zeiss Ag
Cepheid Inc. (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Luminex Corporation
Neogen Corporation (Abtek Biologicals)
OpGen Inc.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Ěý
Ěý
*If Applicable.
